ModivCare ROE 2010-2025 | MODV
Current and historical return on equity (ROE) values for ModivCare (MODV) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| ModivCare ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2025-03-31 | $-0.23B | $-0.09B | 688.72% |
| 2024-12-31 | $-0.20B | $-0.04B | -883.52% |
| 2024-09-30 | $-0.18B | $-0.02B | -256.84% |
| 2024-06-30 | $-0.16B | $0.01B | -138.83% |
| 2024-03-31 | $-0.22B | $0.14B | -145.10% |
| 2023-12-31 | $-0.20B | $0.16B | -98.67% |
| 2023-09-30 | $-0.21B | $0.16B | -80.31% |
| 2023-06-30 | $-0.23B | $0.16B | -75.68% |
| 2023-03-31 | $-0.04B | $0.35B | -10.26% |
| 2022-12-31 | $-0.03B | $0.36B | -9.00% |
| 2022-09-30 | $-0.06B | $0.35B | -15.62% |
| 2022-06-30 | $-0.04B | $0.38B | -9.64% |
| 2022-03-31 | $-0.03B | $0.38B | -6.66% |
| 2021-12-31 | $-0.01B | $0.37B | -1.74% |
| 2021-09-30 | $0.02B | $0.40B | 5.35% |
| 2021-06-30 | $0.07B | $0.41B | 15.76% |
| 2021-03-31 | $0.04B | $0.42B | 9.49% |
| 2020-12-31 | $0.03B | $0.41B | 8.48% |
| 2020-09-30 | $0.03B | $0.41B | 8.19% |
| 2020-06-30 | $0.00B | $0.36B | 0.00% |
| 2020-03-31 | $0.01B | $0.33B | 2.78% |
| 2019-12-31 | $0.00B | $0.32B | -1.12% |
| 2019-09-30 | $-0.02B | $0.40B | -5.65% |
| 2019-06-30 | $-0.02B | $0.39B | -6.01% |
| 2019-03-31 | $-0.03B | $0.32B | -8.75% |
| 2018-12-31 | $-0.03B | $0.31B | -7.14% |
| 2018-09-30 | $0.03B | $0.38B | 8.10% |
| 2018-06-30 | $0.04B | $0.37B | 9.96% |
| 2018-03-31 | $0.05B | $0.40B | 13.78% |
| 2017-12-31 | $0.04B | $0.34B | 11.98% |
| 2017-09-30 | $0.08B | $0.38B | 22.51% |
| 2017-06-30 | $0.07B | $0.36B | 19.90% |
| 2017-03-31 | $0.07B | $0.36B | 20.61% |
| 2016-12-31 | $0.08B | $0.38B | 22.45% |
| 2016-09-30 | $0.07B | $0.31B | 19.93% |
| 2016-06-30 | $0.06B | $0.33B | 18.18% |
| 2016-03-31 | $0.06B | $0.35B | 18.65% |
| 2015-12-31 | $0.07B | $0.37B | 20.49% |
| 2015-09-30 | $0.01B | $0.31B | 3.10% |
| 2015-06-30 | $0.02B | $0.32B | 6.25% |
| 2015-03-31 | $0.02B | $0.31B | 8.64% |
| 2014-12-31 | $0.02B | $0.22B | 10.94% |
| 2014-09-30 | $0.02B | $0.18B | 9.68% |
| 2014-06-30 | $0.02B | $0.18B | 12.68% |
| 2014-03-31 | $0.02B | $0.16B | 12.82% |
| 2013-12-31 | $0.02B | $0.15B | 14.21% |
| 2013-09-30 | $0.02B | $0.15B | 15.07% |
| 2013-06-30 | $0.02B | $0.14B | 13.60% |
| 2013-03-31 | $0.01B | $0.13B | 10.06% |
| 2012-12-31 | $0.01B | $0.12B | 6.91% |
| 2012-09-30 | $0.01B | $0.12B | 7.06% |
| 2012-06-30 | $0.01B | $0.12B | 8.18% |
| 2012-03-31 | $0.02B | $0.11B | 15.09% |
| 2011-12-31 | $0.02B | $0.11B | 16.79% |
| 2011-09-30 | $0.02B | $0.10B | 18.70% |
| 2011-06-30 | $0.02B | $0.10B | 20.77% |
| 2011-03-31 | $0.02B | $0.09B | 20.87% |
| 2010-12-31 | $0.02B | $0.09B | 28.48% |
| 2010-09-30 | $0.03B | $0.08B | 33.78% |
| 2010-06-30 | $0.03B | $0.08B | 38.66% |
| 2010-03-31 | $0.02B | $0.07B | 40.00% |
| 2009-12-31 | $0.02B | $0.06B | 39.62% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.018B | $2.788B |
| ModivCare Inc. is a technology-enabled healthcare services company. It provides a suite of integrated supportive care solutions for public and private payors and their patients. ModivCare Inc., formerly known as The Providence Service Corporation, is based in DENVER. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $143.728B | 26.96 |
| Elevance Health (ELV) | United States | $94.145B | 12.15 |
| CVS Health (CVS) | United States | $81.986B | 10.19 |
| Cencora (COR) | United States | $53.983B | 18.77 |
| Natera (NTRA) | United States | $21.477B | 0.00 |
| DiDi Global (DIDIY) | China | $21.462B | 32.57 |
| BioMerieux (BMXMF) | France | $15.263B | 0.00 |
| Solventum (SOLV) | United States | $12.941B | 13.70 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.036B | 0.00 |
| Revvity (RVTY) | United States | $11.610B | 19.98 |
| Doximity (DOCS) | United States | $11.396B | 59.26 |
| ICON (ICLR) | Ireland | $11.324B | 10.53 |
| CochLear (CHEOY) | Australia | $11.195B | 0.00 |
| Viatris (VTRS) | United States | $10.516B | 3.61 |
| Medpace Holdings (MEDP) | United States | $9.017B | 23.95 |
| Avantor (AVTR) | United States | $8.859B | 12.87 |
| HealthEquity (HQY) | United States | $8.361B | 41.13 |
| Sonic Healthcare (SKHHY) | Australia | $8.215B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.027B | 13.77 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 26.21 |
| Bausch + Lomb (BLCO) | Canada | $4.202B | 24.77 |
| BrightSpring Health Services (BTSG) | United States | $3.894B | 36.05 |
| Sotera Health (SHC) | United States | $3.832B | 21.77 |
| Surgery Partners (SGRY) | United States | $2.982B | 38.77 |
| Alignment Healthcare (ALHC) | United States | $2.952B | 0.00 |
| Concentras Parent (CON) | United States | $2.771B | 16.01 |
| Organon (OGN) | United States | $2.264B | 2.41 |
| Ardent Health Partners (ARDT) | United States | $2.121B | 9.04 |
| Premier (PINC) | United States | $2.101B | 14.38 |
| Progyny (PGNY) | United States | $1.886B | 41.51 |
| PACS (PACS) | United States | $1.698B | 0.00 |
| GeneDx Holdings (WGS) | United States | $1.683B | 64.83 |
| GoodRx Holdings (GDRX) | United States | $1.669B | 31.07 |
| Teladoc Health (TDOC) | United States | $1.289B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.234B | 9.39 |
| Agilon Health (AGL) | United States | $1.229B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.000B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.998B | 0.00 |
| CareDx (CDNA) | United States | $0.911B | 14.23 |
| AMN Healthcare Services Inc (AMN) | United States | $0.866B | 8.11 |
| Embecta (EMBC) | United States | $0.725B | 4.89 |
| QDM (QDMI) | Hong Kong, SAR China | $0.690B | 0.00 |
| Nutex Health (NUTX) | United States | $0.689B | 13.50 |
| Enhabit (EHAB) | United States | $0.530B | 43.58 |
| InnovAge Holding (INNV) | United States | $0.513B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.513B | 13.59 |
| Sonida Senior Living (SNDA) | United States | $0.512B | 0.00 |
| LifeMD (LFMD) | United States | $0.389B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.363B | 0.00 |
| SBC Medicals (SBC) | United States | $0.359B | 0.00 |
| Beauty Health (SKIN) | United States | $0.220B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.202B | 0.00 |
| Oncology Institute (TOI) | United States | $0.193B | 0.00 |
| DocGo (DCGO) | United States | $0.147B | 24.08 |
| Sera Prognostics (SERA) | United States | $0.087B | 0.00 |
| So-Young (SY) | China | $0.087B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.087B | 0.00 |
| KindlyMD (KDLY) | United States | $0.082B | 0.00 |
| OncoCyte (OCX) | United States | $0.080B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.076B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.054B | 0.00 |
| Biodesix (BDSX) | United States | $0.053B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.031B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.011B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |